Literature DB >> 21797844

Microvascular responsiveness in obesity: implications for therapeutic intervention.

Zsolt Bagi1, Attila Feher, James Cassuto.   

Abstract

UNLABELLED: Obesity has detrimental effects on the microcirculation. Functional changes in microvascular responsiveness may increase the risk of developing cardiovascular complications in obese patients. Emerging evidence indicates that selective therapeutic targeting of the microvessels may prevent life-threatening obesity-related vascular complications, such as ischaemic heart disease, heart failure and hypertension. It is also plausible that alterations in adipose tissue microcirculation contribute to the development of obesity. Therefore, targeting adipose tissue arterioles could represent a novel approach to reducing obesity. This review aims to examine recent studies that have been focused on vasomotor dysfunction of resistance arteries in obese humans and animal models of obesity. Particularly, findings in coronary resistance arteries are contrasted to those obtained in other vascular beds. We provide examples of therapeutic attempts, such as use of statins, ACE inhibitors and insulin sensitizers to prevent obesity-related microvascular complications. We further identify some of the important challenges and opportunities going forward. LINKED ARTICLES: This article is part of a themed section on Fat and Vascular Responsiveness. To view the other articles in this section visit http://dx.doi.org/10.1111/bph.2012.165.issue-3.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21797844      PMCID: PMC3315030          DOI: 10.1111/j.1476-5381.2011.01606.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  159 in total

1.  Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF.

Authors:  Rostislav Bychkov; Matthew P Burnham; Gillian R Richards; Gillian Edwards; Arthur H Weston; Michel Félétou; Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Endothelium-derived hyperpolarizing factor : identification and mechanisms of action in human subcutaneous resistance arteries.

Authors:  P Coats; F Johnston; J MacDonald; J J McMurray; C Hillier
Journal:  Circulation       Date:  2001-03-27       Impact factor: 29.690

3.  A proinflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes.

Authors:  Stylianos Kapiotis; Gregor Holzer; Georg Schaller; Markus Haumer; Harald Widhalm; Daniel Weghuber; Bernd Jilma; Georg Röggla; Michael Wolzt; Kurt Widhalm; Oswald F Wagner
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-14       Impact factor: 8.311

4.  Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow.

Authors:  Shu-ichi Saitoh; Cuihua Zhang; Johnathan D Tune; Barry Potter; Takahiko Kiyooka; Paul A Rogers; Jarrod D Knudson; Gregory M Dick; Albert Swafford; William M Chilian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-10-05       Impact factor: 8.311

Review 5.  Endothelium-derived hyperpolarizing factor: where are we now?

Authors:  Michel Félétou; Paul M Vanhoutte
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-03-16       Impact factor: 8.311

6.  Effects of alpha tocopherol and beta carotene supplements on symptoms, progression, and prognosis of angina pectoris.

Authors:  J M Rapola; J Virtamo; S Ripatti; J K Haukka; J K Huttunen; D Albanes; P R Taylor; O P Heinonen
Journal:  Heart       Date:  1998-05       Impact factor: 5.994

7.  Effect of vitamin E and beta carotene on the incidence of angina pectoris. A randomized, double-blind, controlled trial.

Authors:  J M Rapola; J Virtamo; J K Haukka; O P Heinonen; D Albanes; P R Taylor; J K Huttunen
Journal:  JAMA       Date:  1996-03-06       Impact factor: 56.272

8.  Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.

Authors:  Sven Wassmann; Michaela Stumpf; Kerstin Strehlow; Andreas Schmid; Bernhard Schieffer; Michael Böhm; Georg Nickenig
Journal:  Circ Res       Date:  2003-12-29       Impact factor: 17.367

9.  Reduced EDHF responses and connexin activity in mesenteric arteries from the insulin-resistant obese Zucker rat.

Authors:  E J Young; M A Hill; W B Wiehler; C R Triggle; J J Reid
Journal:  Diabetologia       Date:  2008-03-07       Impact factor: 10.122

10.  Modulation of endothelial cell KCa3.1 channels during endothelium-derived hyperpolarizing factor signaling in mesenteric resistance arteries.

Authors:  Kim A Dora; Nicola T Gallagher; Alister McNeish; Christopher J Garland
Journal:  Circ Res       Date:  2008-04-10       Impact factor: 17.367

View more
  17 in total

1.  Obesity and vascular dysfunction: the fat-e of rich and poor.

Authors:  Paul M Vanhoutte
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  Role of Adipose Tissue Endothelial ADAM17 in Age-Related Coronary Microvascular Dysfunction.

Authors:  Huijuan Dou; Attila Feher; Alec C Davila; Maritza J Romero; Vijay S Patel; Vinayak M Kamath; Monika Beck Gooz; R Daniel Rudic; Rudolf Lucas; David J Fulton; Neal L Weintraub; Zsolt Bagi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-05-04       Impact factor: 8.311

Review 3.  Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes.

Authors:  Takayuki Matsumoto; Styliani Goulopoulou; Kumiko Taguchi; Rita C Tostes; Tsuneo Kobayashi
Journal:  Br J Pharmacol       Date:  2015-07-08       Impact factor: 8.739

Review 4.  Overnutrition, mTOR signaling, and cardiovascular diseases.

Authors:  Guanghong Jia; Annayya R Aroor; Luis A Martinez-Lemus; James R Sowers
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-09-24       Impact factor: 3.619

Review 5.  ESC Working Group on Coronary Pathophysiology and Microcirculation position paper on 'coronary microvascular dysfunction in cardiovascular disease'.

Authors:  Teresa Padro; Olivia Manfrini; Raffaele Bugiardini; John Canty; Edina Cenko; Giuseppe De Luca; Dirk J Duncker; Etto C Eringa; Akos Koller; Dimitris Tousoulis; Danijela Trifunovic; Marija Vavlukis; Cor de Wit; Lina Badimon
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

6.  The impact of obesity on the regulation of muscle blood flow during exercise in patients with heart failure with a preserved ejection fraction.

Authors:  Stephen M Ratchford; Joshua F Lee; Kanokwan Bunsawat; Jeremy K Alpenglow; Jia Zhao; Christy L Ma; John J Ryan; Lillian L Khor; D Walter Wray
Journal:  J Appl Physiol (1985)       Date:  2022-04-14

7.  Obesity and statins are both independent predictors of enhanced coronary arteriolar dilation in patients undergoing heart surgery.

Authors:  James Cassuto; Attila Feher; Ling Lan; Vijay S Patel; Vinayak Kamath; Daniel C Anthony; Zsolt Bagi
Journal:  J Cardiothorac Surg       Date:  2013-04-30       Impact factor: 1.637

8.  Oxidative Stress-Dependent Coronary Endothelial Dysfunction in Obese Mice.

Authors:  Ana María Gamez-Mendez; Hilda Vargas-Robles; Amelia Ríos; Bruno Escalante
Journal:  PLoS One       Date:  2015-09-18       Impact factor: 3.240

9.  Upregulation of SK3 and IK1 channels contributes to the enhanced endothelial calcium signaling and the preserved coronary relaxation in obese Zucker rats.

Authors:  Belén Climent; Laura Moreno; Pilar Martínez; Cristina Contreras; Ana Sánchez; Francisco Pérez-Vizcaíno; Albino García-Sacristán; Luis Rivera; Dolores Prieto
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

10.  Preserved endothelial function in human obesity in the absence of insulin resistance.

Authors:  Mariam El Assar; Juan Carlos Ruiz de Adana; Javier Angulo; María Luz Pindado Martínez; Alberto Hernández Matías; Leocadio Rodríguez-Mañas
Journal:  J Transl Med       Date:  2013-10-20       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.